Sites throughout the U.S. and Canada are seeking patients with newly diagnosed or relapsed anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. This clinical trial is designed to determine whether a new non-steroidal treatment, when added to standard of care treatment can improve the remission rate, kidney function, and/or improve vasculitis symptoms. All…...
VF Awards $200,000 in Promising New Research
The VF Board of Directors is pleased to announce that it has selected three new research studies for funding this year. The Vasculitis Foundation collaborates with researchers around the world to fund the most promising studies. The goals of the Research Program are to fund high quality research improve the…...
2015 V-Red Award Winners Announced
Dr. Sarah Durney of Powell Valley Healthcare in Powell, Wyoming, has been selected as a recipient of the 2015 Vasculitis Foundation’s Recognizing Excellence in Diagnostics (RED) Award. Early diagnosis is critical, and Durney, who loves patient interaction and medical sleuthing, reached a preliminary conclusion in under two weeks for patient…...
Fellowship Established in Dr. Gary S. Hoffman’s Honor
The Vasculitis Foundation is pleased to announce the 2016 Gary S. Hoffman Vasculitis Foundation Fellowship in honor of Dr. Hoffman, who has had a profound influence on the lives of people with vasculitis and is recognized as a world leader in vasculitis clinical care and research. Upon the announcement of his…...
